EU Eases GMO Rules To Speed Trials Of COVID-19 Vaccines
Move Should Take Effect ‘As A Matter Of Urgency’
The need to accelerate clinical trials of products for treating and preventing coronavirus has led the EU authorities to propose a more streamlined process for allowing the release of GMO-containing investigational medicinal products into the environment.
